Normal view MARC view ISBD view

Formulation, Characterization and Optimization of Transdermal Drug Delivery Systems for the Treatment of Schizophrenia

By:

Material type: Film

FilmPublication details: Ahmedabad Institute of Pharmacy, Nirma University 2020Description: 179pDDC classification:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode	Item holds
Thesis	NIMA Knowledge Centre Reference	Reference	615.1 AGA (Browse shelf(Opens below))	Not For Loan		PTR00110
CD/DVD	NIMA Knowledge Centre Reference	Reference	615.1 AGA (Browse shelf(Opens below))	Not For Loan		PTR00110-1

Total holds: 0

Previous	No cover image available		No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.1 ACH Neuromedin: A Novel Target for Various Disorders	615.1 ADV Advanced Drug Delivery	615.1 AGA An Overview of Formulations for the Treatment of Pulmonary Fibrosis	615.1 AGA Formulation, Characterization and Optimization of Transdermal Drug Delivery Systems for the Treatment of Schizophrenia	615.1 AGA Formulation, Characterization and Optimization of Transdermal Drug Delivery Systems for the Treatment of Schizophrenia	615.1 BHA Effect of Oryzanol and Formulation-X on atherothrombotic risk factors in poloxamer-407 induced hyperlipidemia in mice	615.1 BHA Effect of Oryzanol and Formulation-X on atherothrombotic risk factors in poloxamer-407 induced hyperlipidemia in mice	Next

Guided by Dr. Mayur M. Patel

There are no comments on this title.

to post a comment.